Ion mobility spectrometry (IMS) is a high-throughput separation technique that defines chemical substances based upon their gas-phase ion mobilities. Ion mobility spectrometry separates ions in a drift tube under the impact of an electric field according to their shape and size. Ion mobility spectrometry is a fast, cheap, portable, and sensitive technique for detection of different diseases.
Ion mobility spectrometry is able to diagnose any volatile metabolites in biological samples and serve as a reliable and non-invasive instrumental substitute for the diagnosis of different diseases. In medicine, Ion mobility spectrometry supports non-invasive diagnosis of chronic obstructive pulmonary disease, bronchial carcinoma, and other diseases.
Ion mobility spectrometry is able to analyze various samples like breath, blood, faeces, urine, and other biological samples. Ion mobility spectrometry meets all the requirements of becoming a low cost, secure, fast, robust and real-time tool for diagnosis of different diseases.
The use of Ion mobility spectrometry in pharmaceutical companies for quality assurance and drug composition detection has been burgeoning. Ion mobility spectrometry is also required in cleaning validations, verifying that reaction vessels are adequately clean to proceed with the next batch of active pharmaceutical ingredients.
These factors are expected to drive the market of Ion mobility spectrometry. Increasing demand for Ion mobility spectrometry because of their improved efficiency in diagnosis of various serious medical conditions, direct formulation analysis abilities and their ability to interpret the data in real-time is expected to propel the demand for Ion mobility spectrometry over the course of forecast.
Quality in pharmaceutical companies is a vital process and they are always in look for advanced, portable, quick, efficient and low cost techniques for this purpose. All these requirements are successfully met by Ion mobility spectrometry and due to these reasons it is expected that market of Ion mobility spectrometry would propel in the forecasted period.
According to the International Journal of Spectroscopy, Vaginal infections globally affect more than 15% of the female population who are in their reproductive age. Though, the diagnosis of vaginal infection is troublesome, it can be quickly and effectively detected by using Ion mobility spectrometry.
Such advancements and abilities is expected to fuel the market of Ion mobility spectrometry globally. However, lack of advancement in hospital and diagnostic infrastructure and lack of professionals is anticipated to slow down the market in some regions.
Based on the technological advancements, the global Ion mobility spectrometry market is classified into three types, namely, Ion Mobility Mass Spectrometry (IM-MS), Drift-time ion mobility spectrometry (DTIMS), Field-asymmetric ion mobility spectrometry (FAIMS), and Travelling-wave ion mobility spectrometry (TWIMS).
Field-asymmetric ion mobility spectrometry are expected to hold the maximum revenue share in the Ion mobility spectrometry market. The robust, responsive, inexpensive and portable aspects of Ion mobility spectrometry devices make them convenient tools for quality control and quality analysis of pharmaceuticals.
The features like environmental monitoring and disease diagnosis is expected to propel the global market of Ion mobility spectrometry in healthcare sector exponentially.
Geographically, the global Ion mobility spectrometry market is segmented into viz. North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA. North America is expected to be a dominant market in the global Ion mobility spectrometry market because of the presence of well-established pharmaceutical and healthcare infrastructure and availability of advanced healthcare facilities.
Expanding pharmaceutical industries and healthcare unit establishments in the Asia Pacific is expected to hold a substantial growth rate of Ion mobility spectrometry market.
Some of the market participants in the Global Ion mobility spectrometry market identified across the value chain include: Agilent Technologies, Inc, Bruker, G.A.S. Gesellschaft für analytische Sensorsysteme mbH BioMedizinZentrumDortmund, AB Sciex, Nuctech Company limited, EXCELLIMS All Rights Reserved, Owlstone Inc, MaSa Tech, s.r.o., and others.
The research report on Ion mobility spectrometry presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies.
The research report on Ion mobility spectrometry provides analysis and information according to market segments such as geographies, application, and industry.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Tentatively, the global Ion mobility spectrometry market can be segmented on the basis of the technology, application, end user, and geography.
On the basis of technology, the global Ion mobility spectrometry market is segmented as:
On the basis of application, the global Ion mobility spectrometry market is segmented as:
On the basis of end user, the global Ion mobility spectrometry market is segmented as:
Explore Similar Insights
Ion Mobility Spectrometry Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
